Literature DB >> 18638434

Gout and coronary artery disease: epidemiologic clues.

Eswar Krishnan1.   

Abstract

Gout is the leading cause of inflammatory arthritis, typically affecting men and characterized by intermittent, abrupt onset of intense inflammation. The association between gout, atherosclerosis, and vascular disease has been noted in medical literature since the end of the 19th century, yet it has not been well studied. This review critically appraises the few epidemiologic studies that ask if gout is a risk factor for coronary artery disease. An exhaustive literature search using search engines and cross-referencing found four major studies and several smaller studies that have evaluated gout as a risk factor for coronary artery disease. The available studies were too heterogeneous to permit formal meta-analysis. Although there are gaps in evidence pointing to a causative pathway, overall, evidence exists for a relationship between gouty arthritis and coronary artery disease independent of traditional risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18638434     DOI: 10.1007/s11926-008-0039-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  47 in total

1.  URATE DIURETIC THERAPY IN CHRONIC GOUT; A COMPARATIVE STUDY OF PROBENECID AND SULFINPYRAZONE.

Authors:  E E VELAYOS; C J SMYTH
Journal:  Arch Intern Med       Date:  1965-08

2.  Specific vascular changes in gout.

Authors:  E F TRAUT; A A KNIGHT; P B SZANTO; E W PASSERELLI
Journal:  J Am Med Assoc       Date:  1954-10-09

3.  Gout and coronary heart disease: the Framingham Study.

Authors:  R D Abbott; F N Brand; W B Kannel; W P Castelli
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

4.  Post-cardiac transplantation gout: incidence of therapeutic complications.

Authors:  A E Wluka; P F Ryan; A M Miller; M Richardson; P J Bergin; J L Page; D S Esmore
Journal:  J Heart Lung Transplant       Date:  2000-10       Impact factor: 10.247

Review 5.  Uric acid and cardiovascular risk.

Authors:  Michael H Alderman
Journal:  Curr Opin Pharmacol       Date:  2002-04       Impact factor: 5.547

Review 6.  Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

Authors:  N R Madamanchi; Z S Hakim; M S Runge
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

Review 7.  Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view.

Authors:  P M Ridker
Journal:  Blood Coagul Fibrinolysis       Date:  1999-02       Impact factor: 1.276

8.  Long-term cardiovascular mortality among middle-aged men with gout.

Authors:  Eswar Krishnan; Kenneth Svendsen; James D Neaton; Greg Grandits; Lewis H Kuller
Journal:  Arch Intern Med       Date:  2008-05-26

9.  Independent impact of gout on mortality and risk for coronary heart disease.

Authors:  Hyon K Choi; Gary Curhan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

10.  Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.

Authors:  E Pascual
Journal:  Arthritis Rheum       Date:  1991-02
View more
  8 in total

1.  Patient-reported outcomes in chronic gout: a report from OMERACT 10.

Authors:  Jasvinder A Singh; Will J Taylor; Lee S Simon; Puja P Khanna; Lisa K Stamp; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Michael A Becker; Patricia A MacDonald; Omar Dabbous; Vibeke Strand; Nicola D Dalbeth; Daniel Aletaha; N Lawrence Edwards; H Ralph Schumacher
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis.

Authors:  Smriti K Raychaudhuri; Sidhartha Chatterjee; Caroline Nguyen; Manpreet Kaur; Ishwarlal Jialal; Siba P Raychaudhuri
Journal:  Metab Syndr Relat Disord       Date:  2010-08       Impact factor: 1.894

3.  Hyperuricemia and incident heart failure.

Authors:  Eswar Krishnan
Journal:  Circ Heart Fail       Date:  2009-08-06       Impact factor: 8.790

4.  Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

Authors:  Lada Beara-Lasic; Michael H Pillinger; David S Goldfarb
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-02-09

5.  Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction.

Authors:  Eswar Krishnan; Bhavik J Pandya; Bharathi Lingala; Ali Hariri; Omar Dabbous
Journal:  Arthritis Res Ther       Date:  2012-01-17       Impact factor: 5.156

6.  The risk of atrial fibrillation in patients with gout: a nationwide population-based study.

Authors:  Yu-Jui Kuo; Tzu-Hsien Tsai; Hui-Ping Chang; Sarah Chua; Sheng-Ying Chung; Cheng-Hsu Yang; Cheng-Jei Lin; Chiung-Jen Wu; Chi-Ling Hang
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

7.  Association of gout with CAD and effect of antigout therapy on CVD risk among gout patients.

Authors:  Chon-Haw Tsai; Kuang-Hsi Chang; Wei-Shih Huang; Cheng-Li Lin
Journal:  J Investig Med       Date:  2020-02-24       Impact factor: 2.895

8.  Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  RMD Open       Date:  2018-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.